Tuesday, May 6, 2025
Facebook Linkedin Twitter
HomeTagsDebiopharm

Debiopharm

Biotechnology

Debiopharm and Oncodesign Services launch strategic collaboration to advance radiopharmaceuticals in preclinical research

News Desk -
Debiopharm Research & Manufacturing SA, a global biopharmaceutical company based in Switzerland dedicated to curing cancer and infectious diseases, and Oncodesign Services, a leading...
Biotechnology

Debiopharm Announces Oncology Research Advancements at AACR 2022 for Novel Cancer Compounds and Drug Delivery Technologies

PR Newswire -
Debiopharm, an oncology and infectious disease focused biopharmaceutical company based in Switzerland, today announced data releases on 3 investigational products including Debio 0123 (Selective...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us